GWANC
GILD icon

Guardian Wealth Advisors (North Carolina)’s Gilead Sciences GILD Stock Holding History

Guardian Wealth Advisors (North Carolina)’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$422K Sell
3,029
-96
-3% -$13.4K 0.03% 238
2025
Q4 		$384K Buy
3,125
+24
+0.8% +$2.92K 0.02% 258
2025
Q3 		$344K Hold
3,101
– – 0.02% 268
2025
Q2 		$344K Buy
3,101
+124
+4% +$13.2K 0.02% 248
2025
Q1 		$334K Sell
2,977
-250
-8% -$25.8K 0.03% 237
2024
Q4 		$298K Buy
3,227
+601
+23% +$54.1K 0.02% 249
2024
Q3 		$220K Buy
+2,626
New +$200K 0.02% 254
2024
Q1 		– Sell
-3,395
Closed -$275K – 461
2023
Q4 		$275K Sell
3,395
-24
-0.7% -$1.87K 0.04% 198
2023
Q3 		$256K Sell
3,419
-148
-4% -$11.4K 0.04% 198
2023
Q2 		$275K Buy
3,567
+174
+5% +$13.9K 0.05% 179
2023
Q1 		$282K Buy
3,393
+86
+3% +$7.12K 0.05% 171
2022
Q4 		$284K Buy
+3,307
New +$262K 0.05% 156

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Guardian Wealth Advisors (North Carolina)'s GILD Position: Q1 2026 in Review

Guardian Wealth Advisors (North Carolina) reduced its Gilead Sciences (GILD) stake by 3.1% in Q1 2026, selling an estimated $13.4K and leaving 3,029 shares worth $422K. The position accounts for 0.03% of the portfolio, ranked #238.

Guardian Wealth Advisors (North Carolina) first reported a position in GILD in Q4 2022 and has held it in 12 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Guardian Wealth Advisors (North Carolina) held 3,029 shares of Gilead Sciences worth $422K as of Q1 2026.
  • Guardian Wealth Advisors (North Carolina) sold 96 Gilead Sciences shares in Q1 2026, an estimated $13.4K.
  • Gilead Sciences made up 0.03% of Guardian Wealth Advisors (North Carolina)'s portfolio in Q1 2026, its #238 holding.
  • Guardian Wealth Advisors (North Carolina) first reported a position in Gilead Sciences in Q4 2022 and has held it in 12 quarters since.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Guardian Wealth Advisors (North Carolina)'s 13F filing for Q1 2026, filed 15 May 2026.